We demonstrate that the tumor-specific modules are enriched in pathways, including cell–cell communication and SMAD2/3/4 transcriptional activity, with identified upstream transcriptional factors including TEAD1 and FOXA1. We further show the clinical prognostic significance of these discoveries in clinical samples. The gene discussed is TEAD1; the disease is neoplasm.